Cargando…

Development and Validation of a Novel Dual Luciferase Reporter Gene Assay to Quantify Ebola Virus VP24 Inhibition of IFN Signaling

The interferon (IFN) system is the first line of defense against viral infections. Evasion of IFN signaling by Ebola viral protein 24 (VP24) is a critical event in the pathogenesis of the infection and, hence, VP24 is a potential target for drug development. Since no drugs target VP24, the identific...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fanunza, Elisa, Frau, Aldo, Sgarbanti, Marco, Orsatti, Roberto, Corona, Angela, Tramontano, Enzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850405/ https://www.ncbi.nlm.nih.gov/pubmed/29495311 http://dx.doi.org/10.3390/v10020098

Ejemplares similares

Antiviral Agents Against Ebola Virus Infection: Repositioning Old Drugs and Finding Novel Small Molecules
por: Fanunza, Elisa, et al.
Publicado: (2018)

Relevance of Ebola virus VP35 homo-dimerization on the type I interferon cascade inhibition
por: Di Palma, Francesco, et al.
Publicado: (2019)

Intracellular human antibody fragments recognizing the VP35 protein of Zaire Ebola filovirus inhibit the protein activity
por: Flego, Michela, et al.
Publicado: (2019)

The Methanolic Extract of Perilla frutescens Robustly Restricts Ebola Virus Glycoprotein-Mediated Entry
por: Kuo, Yu-Ting, et al.
Publicado: (2021)

An Optimized Transient Dual Luciferase Assay for Quantifying MicroRNA Directed Repression of Targeted Sequences
por: Moyle, Richard L., et al.
Publicado: (2017)

Functional Importance of Hydrophobic Patches on the Ebola Virus VP35 IFN-Inhibitory Domain
por: Kasajima, Nodoka, et al.
Publicado: (2021)

Improved Dual-Luciferase Reporter Assays for Nuclear Receptors
por: Paguio, Aileen, et al.
Publicado: (2010)

The Ebola Virus Interferon Antagonist VP24 Undergoes Active Nucleocytoplasmic Trafficking
por: Harrison, Angela R., et al.
Publicado: (2021)

Ebola virus VP24 interacts with NP to facilitate nucleocapsid assembly and genome packaging
por: Banadyga, Logan, et al.
Publicado: (2017)

An enzymatic assay based on luciferase Ebola virus-like particles for evaluation of virolytic activity of antimicrobial peptides
por: Peskova, Marie, et al.
Publicado: (2017)

Characterization of L1 retrotransposition with high-throughput dual-luciferase assays
por: Xie, Yi, et al.
Publicado: (2011)

The Minor Matrix Protein VP24 from Ebola Virus Lacks Direct Lipid-Binding Properties
por: Su, Yuan, et al.
Publicado: (2020)

Application of the dual-luciferase reporter assay to the analysis of promoter activity in Zebrafish embryos
por: Alcaraz-Pérez, Francisca, et al.
Publicado: (2008)

Editorial: Viruses, innate immunity, and antiviral strategies: from basic research to clinical applications
por: Fanunza, Elisa, et al.
Publicado: (2023)

Effect of Ebola virus proteins GP, NP and VP35 on VP40 VLP morphology
por: Johnson, Reed F, et al.
Publicado: (2006)

Zika virus NS2A inhibits interferon signaling by degradation of STAT1 and STAT2
por: Fanunza, Elisa, et al.
Publicado: (2021)

INMI1 Zika Virus NS4B Antagonizes the Interferon Signaling by Suppressing STAT1 Phosphorylation
por: Fanunza, Elisa, et al.
Publicado: (2021)

Secreted dual reporter assay with Gaussia luciferase and the red fluorescent protein mCherry
por: Wider, Diana, et al.
Publicado: (2017)

The Ebola Virus Interferon Antagonist VP24 Directly Binds STAT1 and Has a Novel, Pyramidal Fold
por: Zhang, Adrianna P. P., et al.
Publicado: (2012)

Membrane binding and bending in Ebola VP40 assembly and egress
por: Stahelin, Robert V.
Publicado: (2014)

Regulation of Ebola virus VP40 matrix protein by SUMO
por: Baz-Martínez, Maite, et al.
Publicado: (2016)

Identification of Continuous Human B-Cell Epitopes in the VP35, VP40, Nucleoprotein and Glycoprotein of Ebola Virus
por: Becquart, Pierre, et al.
Publicado: (2014)

Integrated Computational Approach for Virtual Hit Identification against Ebola Viral Proteins VP35 and VP40
por: Mirza, Muhammad Usman, et al.
Publicado: (2016)

Multiplexing fluorogenic esterase-based viability assay with luciferase assays
por: Ohgane, Kenji, et al.
Publicado: (2019)

Inhibitor bias in luciferase-based luminescence assays
por: Yonchev, Dimitar, et al.
Publicado: (2020)

The quest for effective Ebola treatment: Ebola VP35 is an evidence-based target for dsRNA drugs
por: Mitchell, William M, et al.
Publicado: (2014)

Correction: The Ebola Virus Interferon Antagonist VP24 Directly Binds STAT1 and Has a Novel, Pyramidal Fold
por: Zhang, Adrianna P. P., et al.
Publicado: (2013)

A Single Phosphorodiamidate Morpholino Oligomer Targeting VP24 Protects Rhesus Monkeys against Lethal Ebola Virus Infection
por: Warren, Travis K., et al.
Publicado: (2015)

Expression of the Ebola Virus VP24 Protein Compromises the Integrity of the Nuclear Envelope and Induces a Laminopathy-Like Cellular Phenotype
por: Vidal, Santiago, et al.
Publicado: (2021)

Sensitive Dual Color In Vivo Bioluminescence Imaging Using a New Red Codon Optimized Firefly Luciferase and a Green Click Beetle Luciferase
por: Mezzanotte, Laura, et al.
Publicado: (2011)

The Ebola Virus VP35 Protein Is a Suppressor of RNA Silencing
por: Haasnoot, Joost, et al.
Publicado: (2007)

Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction
por: Pleet, Michelle L., et al.
Publicado: (2016)

Cheminformatics-Based Study Identifies Potential Ebola VP40 Inhibitors
por: Broni, Emmanuel, et al.
Publicado: (2023)

dsRNA binding characterization of full length recombinant wild type and mutants Zaire ebolavirus VP35
por: Zinzula, Luca, et al.
Publicado: (2012)

Luciferase Reporter Assay System for Deciphering GPCR Pathways
por: Cheng, Zhijie, et al.
Publicado: (2010)

Relative Quantification of Protein-Protein Interactions Using a Dual Luciferase Reporter Pull-Down Assay System
por: Jia, Shuaizheng, et al.
Publicado: (2011)

A novel dual luciferase based high throughput assay to monitor autophagy in real time in yeast S. cerevisiae
por: Mishra, Piyush, et al.
Publicado: (2017)

Corrigendum: Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction
por: Pleet, Michelle L., et al.
Publicado: (2018)

Ebola virus VP35 has novel NTPase and helicase-like activities
por: Shu, Ting, et al.
Publicado: (2019)

Ebola Virus VP40 Modulates Cell Cycle and Biogenesis of Extracellular Vesicles
por: Pleet, Michelle L, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_coebf3b9atrchfqmv9jipklmqu